Anesthetic management of percutaneous nephrolithotripsy in an 11 year old girl with Rett Syndrome: a case report
R. N. Naghiyev, F. A. Ahmadov, E. M. Nasibova
Pediatric Anesthesia and Critical Care Journal (PACCJ) · 2025
doi:10.14587/paccj.2025.8 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Rett syndrome (RTT) is a rare X-linked neurodevelopmental disorder primarily affecting fe- males, characterized by severe cognitive impairment, au- tonomic dysregulation, epilepsy, and abnormal respira- tory patterns. Anesthetic management in these patients is particularly challenging due to increased sensitivity to medications, airway instability, and potential for postop- erative complications. We report the anesthetic manage- ment of an 11-year-old girl (15 kg) with Rett syndrome undergoing elective left-sided percutaneous nephrolitho- tripsy for staghorn calculus. Premedication was adminis- tered with oral midazolam (0.5 mg/kg) mixed in cherry juice. Stepwise inhalational induction with sevoflurane was performed, followed by successful orotracheal intu- bation without neuromuscular blockade. A single-shot caudal block with bupivacaine 0.5% (50 mg), dexame- thasone 4 mg, and normal saline was performed. No in- traoperative opioids or muscle relaxants were used. In- traoperative hemodynamics and postoperative recovery were stable. This case illustrates that sevoflurane-based anesthesia combined with caudal block, without the use of opioids or neuromuscular blockers, is safe and effec- tive for children with RTT undergoing urological sur- gery. Regional anesthesia techniques can enhance peri- operative stability in patients with complex neurodevel- opmental disorders.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.